Sonal Pharmaceuticalss Profile
Key Indicators
- Authorised Capital ₹ 1.30 M
- Company Age 49 Year, 3 Months
- Open Charges ₹ 3.52 M
About Sonal Pharmaceuticalss
Sonal Pharmaceuticalss Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 November 1975 and has a history of 49 years and three months. Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.30 M and a paid-up capital of Rs 0.00.
The company currently has active open charges totaling ₹3.52 M.
Company Details
- Location Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1975PTC018642
- Company No.
018642
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 1975
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sonal Pharmaceuticalss?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Sonal Pharmaceuticalss.
Enhance accessibility to Sonal Pharmaceuticalss's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sonal Pharmaceuticalss?
Unlock access to Sonal Pharmaceuticalss's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.52 M
₹0
Charges Breakdown by Lending Institutions
- Gujarat State Financial Corporation : 0.26 Cr
- Central Bank Of India : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Oct 1981 | Central Bank Of India | ₹0.50 M | Open |
| 06 Dec 1979 | Central Bank Of India | ₹0.40 M | Open |
| 15 May 1978 | Gujarat State Financial Corporation | ₹0.15 M | Open |
| 16 Nov 1976 | Gujarat State Financial Corporation | ₹2.33 M | Open |
| 15 May 1970 | Gujarat State Financial Corporation | ₹0.15 M | Open |
How Many Employees Work at Sonal Pharmaceuticalss?
Unlock and access historical data on people associated with Sonal Pharmaceuticalss, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sonal Pharmaceuticalss, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sonal Pharmaceuticalss's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.